Evolus, Inc.

NasdaqGM:EOLS Rapporto sulle azioni

Cap. di mercato: US$905.4m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Evolus Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Evolus has a total shareholder equity of $19.3M and total debt of $120.9M, which brings its debt-to-equity ratio to 626.1%. Its total assets and total liabilities are $233.8M and $214.5M respectively.

Informazioni chiave

626.1%

Rapporto debito/patrimonio netto

US$120.92m

Debito

Indice di copertura degli interessin/a
ContantiUS$93.67m
Patrimonio nettoUS$19.31m
Totale passivitàUS$214.46m
Totale attivitàUS$233.77m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Evolus Continues To Make Progress

Aug 02

Evolus, Inc. (NASDAQ:EOLS) Looks Just Right With A 32% Price Jump

Aug 02
Evolus, Inc. (NASDAQ:EOLS) Looks Just Right With A 32% Price Jump

Evolus (NASDAQ:EOLS) Is Making Moderate Use Of Debt

Jul 13
Evolus (NASDAQ:EOLS) Is Making Moderate Use Of Debt

Evolus: Chiseling Away At The Aesthetic Market

May 22

Analysts Are Updating Their Evolus, Inc. (NASDAQ:EOLS) Estimates After Its First-Quarter Results

May 10
Analysts Are Updating Their Evolus, Inc. (NASDAQ:EOLS) Estimates After Its First-Quarter Results

Evolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028

Mar 20

The Evolus, Inc. (NASDAQ:EOLS) Full-Year Results Are Out And Analysts Have Published New Forecasts

Mar 10
The Evolus, Inc. (NASDAQ:EOLS) Full-Year Results Are Out And Analysts Have Published New Forecasts

Evolus, Inc. (NASDAQ:EOLS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Jan 18
Evolus, Inc. (NASDAQ:EOLS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Evolus, Inc.'s (NASDAQ:EOLS) Shares Climb 27% But Its Business Is Yet to Catch Up

Jan 18
Evolus, Inc.'s (NASDAQ:EOLS) Shares Climb 27% But Its Business Is Yet to Catch Up

Would Evolus (NASDAQ:EOLS) Be Better Off With Less Debt?

Jun 16
Would Evolus (NASDAQ:EOLS) Be Better Off With Less Debt?

Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Nov 06
Does Evolus (NASDAQ:EOLS) Have A Healthy Balance Sheet?

Evolus concludes certain royalty payments related to settlement of IP rights dispute

Sep 21

Evolus: Turning That Frown Upside Down

Sep 11

Evolus appoints Experian's exec as CFO

Aug 30

Is Evolus (NASDAQ:EOLS) Using Too Much Debt?

Aug 04
Is Evolus (NASDAQ:EOLS) Using Too Much Debt?

Evolus Q2 2022 Earnings Preview

Aug 01

Is Evolus (NASDAQ:EOLS) Using Debt Sensibly?

Mar 21
Is Evolus (NASDAQ:EOLS) Using Debt Sensibly?

Analisi della posizione finanziaria

Passività a breve termine: EOLS's short term assets ($158.1M) exceed its short term liabilities ($54.1M).

Passività a lungo termine: EOLS's short term assets ($158.1M) do not cover its long term liabilities ($160.3M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 141.1% ) di EOLS è considerato alto.

Riduzione del debito: EOLS's debt to equity ratio has increased from 176.9% to 626.1% over the past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: EOLS has sufficient cash runway for more than 3 years based on its current free cash flow.

Previsione Cash Runway: Insufficient data to determine if EOLS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Scoprire le aziende sane